We are pleased to share that Biocytogen will be a sponsor of the 2025 Nonclinical Safety Strategies for New Modalities Symposium at San Francisco, CA. This meeting will feature NorCal SOT Award winners' talks and a student research poster session, offering valuable perspectives on nonclinical safety strategies. Join us to engage with industry experts and explore the latest drug development and toxicology innovations!
What is NorCal SOT Spring Symposium?
The NorCal SOT Spring Symposium is an annual event organized by the Northern California Regional Chapter of the Society of Toxicology (NorCal SOT). This symposium provides a platform for toxicologists and related professionals to discuss current topics, share research findings, and network with peers. Each year, the seminar focuses on a specific theme relevant to the field.
Event Overview
Date: May 20, 2025
Venue: Genentech Building 85, 601 Gateway Blvd, South San Francisco, CA
Event Schedule
The NorCal SOT Spring Symposium is a one-day event. It will feature talkies from 2025 NorCal SOT Award winners and a poster session with students' research showcase. For more event details, feel free to refer to the NorCal Events.
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you at the 2025 NorCal SOT Spring Symposium in San Francisco, CA!
